FDA official logo
GSRS logo
PFDA official logo

BALORAMOTIDE

  • UNII: 9T6PW6J6MA
  • Preferred Substance Name: BALORAMOTIDE

  • 2207581-19-7
  • AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, RECOMBINANT
  • BALORAMOTIDE [INN]
  • CANCER TESTIS ANTIGEN NY-ESO-1 (RECOMBINANT HUMAN)
  • CANCER/TESTIS ANTIGEN 1, RECOMBINANT
  • GLYCYL-L-PROLYL-HUMAN CANCER/TESTIS ANTIGEN 1 (AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, L ANTIGEN FAMILY MEMBER 2 (LAGE-2), CANCER/TESTIS ANTIGEN 6.1, CT6.1)
  • L ANTIGEN FAMILY MEMBER 2, RECOMBINANT
  • LAGE-2, RECOMBINANT
  • RECOMBINANT NY-ESO-1 PROTEIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.